`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`COALITION FOR AFFORDABLE DRUGS X LLC,
`
`Petitioner,
`
`ANACOR PHARMACEUTICALS, INC.,
`Patent Owner.
`
`Case No. IPR2015-01776
`
`Patent No. 7,582,621
`
`PATENT OWNER’S MOTION FOR ADMISSION PRO HAC VICE OF
`
`GEORGE F. PAPPAS UNDER 37 C.F.R. § 42.10
`
`
`
`lPR20l5—01776
`
`1.
`
`Relief Requested
`
`Pursuant to 37 C.F.R. § 42.10, and in accordance with the Board’s Order,
`
`. Paper No. 7 in Case IPR2013—00639, and the Notice of Filing Date Accorded to
`
`Petition (Paper No. 4), Patent Owner requests that the Board admit George F.
`
`Pappas pro hac vice in this proceeding.
`
`II.
`
`Statement of Facts
`
`37 C.F.R. §42.l0(c) states that the Board “may recognize counsel pro hac
`
`vice during a proceeding upon a showing of good cause, subject to the condition
`
`that lead counsel be a registered practitioner and to any other conditions as the
`
`Board may impose.
`
`For example, where the lead counsel
`
`is a registered
`
`practitioner, a motion to appear pro hac vice by counsel who is not a registered
`
`practitioner may be granted upon showing that counsel is an experienced litigating
`
`attorney and has an established familiarity with the subject matter at issue in the
`
`proceeding. The facts, supported by the attached Declaration of George F. Pappas
`
`in Support of Patent Owner’s Motion for Admission Pro Hac Vice (“Pappas
`
`Declaration”), establish good cause to admit Mr. Pappas pro hac vice in this
`
`proceeding.
`
`1.
`
`2.
`
`Lead counsel, Andrea G. Reister, is a registered practitioner.
`
`Counsel, George F. Pappas, is an experienced litigating attorney in his
`
`fortieth year of law practice. Pappas Decl. at ll 10. Mr. Pappas has been litigating
`
`
`
`IPR2015—O1776
`
`patent cases since 1989 and has served as trial counsel
`
`in over sixty patent
`
`infringement cases. Id. Mr. Pappas is a member in good standing of the Maryland
`
`State Bar and the District of Columbia Bar.
`
`Id. at ‘ll 2. He is also admitted to
`
`practice in the United States Supreme Court, the United States Court of Appeals
`
`for the Second Circuit, the United States Court of Appeals for the Fourth Circuit,
`
`the United States Court of Appeals for the Sixth Circuit, the United States Court of
`
`Appeals for the Seventh Circuit, the United States Court of Appeals for the District
`
`of Columbia Circuit, the United States Court of Appeals for the Federal Circuit, the
`
`United States District Court for the District of Maryland, the United States District
`
`Court for the District of Columbia, the United States District Court for the District
`
`of Colorado, and the United States Court of Federal Claims. Id.
`
`3.
`
`On May 27, 2016, Mr. Pappas was admitted to practice before this
`
`Board pro hac Vice in IPR2015—O1537. See Momenta Pharm., Inc. v. Bristol—Myers
`
`Squibb Co., IPR2015—01537, Paper No. 22 (P.T.A.B. May 27, 2016); Pappas Decl.
`
`at ll 3.
`
`4.
`
`Mr. Pappas has familiarity with the subject matter and patent at issue
`
`in this proceeding, U.S. Patent No. 7,582,621 (“the ’62l Patent”), including its
`
`prosecution history, the related U.S. Patent No. 7,767,657, and the scientific field
`
`to which the ’62l Patent is addressed. Pappas Decl. at ‘H11. Mr. Pappas has
`
`worked with Anacor Pharmaceuticals, Inc., the Patent Owner in this proceeding,
`
`
`
`IPR2015-01776
`
`and lead counsel to develop the responses to Petitioner’s invalidity challenges. Id.
`
`Specifically, Mr. Pappas was involved with retaining experts and working with
`
`those experts, whose declarations support the Patent Owner Response.
`
`Id. Mr.
`
`Pappas was also involved in developing the strategy relating to Anacor’s Patent
`
`Owner Response.
`
`Id. All of the above activities required developing a thorough
`
`understanding of the patent at
`
`issue in this proceeding,
`
`the prior art, and the
`
`relevant scientific field. Id.
`
`5.
`
`Mr. Pappas has read and will comply with the Office Patent Trial
`
`Guide and the Board’s Rules for Practice for Trials set forth in Part 42 of the
`
`C.F.R., and he agrees to be subject to the USPTO Rules of Professional Conduct
`
`set forth in 37 C.F.R. §§ 11.100 et seq. and disciplinary jurisdiction under 37
`
`C.F.R. § 11.19(a). Id. at ‘W 7-8. Mr. Pappas is contemporaneously submitting pro
`
`hac vice applications on behalf of Patent Owner in the co-pending proceedings
`
`IPR2015—01780 and IPR2015—01785. Id. at ll 9.
`
`III. Analysis
`
`The facts contained in the Statement of Facts above, and contained in the
`
`Pappas Declaration, establish that there is good cause to admit Mr. Pappas pro hac
`
`vice in this proceeding, under 37 C.F.R. §42.10. Lead counsel is a registered
`
`practitioner, Mr. Pappas is an experienced litigating attorney, and Mr. Pappas has
`
`an established familiarity with the subject matter at issue in this proceeding.
`
`
`
`IPR2015—01776
`
`IV. Conclusion
`
`For the foregoing reasons, Patent Owner respectfully requests that the Board
`
`admit George F. Pappas pro hac vice in this proceeding.
`
`Dated: June 30, 2016
`
`Respectfully submitted,
`
`
`Andrea G. Reister X,
`Registration Nof: 36,253
`COVINGTON & BURLING LLP
`
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`(202) 662-6000
`Attorneys for Patent Owner
`
`
`
`CERTIFICATE OF SERVICE
`
`IPR2015—01776
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 30th day of June 2016,
`
`the foregoing Patent Owner’s Motion for Admission Pro Hac Vice of George F.
`
`Pappas Under 37 C.F.R. § 42.10 was served via electronic mail by agreement of
`
`the parties, on the following counsel of record for petitioner.
`
`Jeffrey D. Blake
`Kathleen E. Ott
`
`Peter A. Gergely
`Ryan James Fletcher
`Brent E. Routman
`
`KerydinIPR@merchantgould.com
`Merchant & Gould PC
`
`V
`
`Dated: June 30, 2016
`
`C/sf “vflréizfiéw 5“ -
` Andrea G. Reis
`r,
`Registration
`0.: 36,253
`
`
`/I